Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management

Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management

The most common form of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC), which comprises some 85% of all cases. Currently, this is the fourth highest cause of cancer mortality worldwide and its incidence is rising steeply. Commonly applied clinical therapies offer limited chance of a la...

Full description

Bibliographic Details
Main Authors: Valerie Jentzsch, James A. A. Davis, Mustafa B. A. Djamgoz
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
pancreatic cancer
PDAC
gemcitabine
integrated management
scheduling
diet
Online Access:https://www.mdpi.com/2072-6694/12/11/3096

Similar Items

Similar Items